PAs as principal investigators of FDA-regulated clinical trials

Colleen Elizabeth Gosa Nalepinski1

  • 1Colleen Elizabeth Gosa Nalepinski is decentralized clinical trials director in research nursing and phlebotomy solutions at IQVIA in Durham, N.C.; a clinical assistant professor at Marquette University in Milwaukee, Wisc.; and a principal investigator at Spaulding Clinical Research in West Bend, Wisc. The author has disclosed no potential conflicts of interest, financial or otherwise.

Insights

Physician Associates/Assistants (PAs) can serve as principal investigators in FDA-regulated clinical trials, challenging a common misconception. This article clarifies guidelines and provides a plan to support PAs in this crucial research role.

Area of Science:

  • Clinical Research
  • Regulatory Affairs
  • Medical Practice

Background:

  • A prevalent misconception suggests only physicians can lead FDA-regulated clinical trials.
  • This limits the potential pool of qualified principal investigators.

Approach:

  • This article systematically reviews current FDA guidelines and relevant literature.
  • It analyzes the regulatory framework governing PI eligibility for human clinical trials.
  • An implementation strategy is proposed to address and rectify the existing misconception.

Key Points:

  • Physician Associates/Assistants (PAs) are legally and ethically qualified to serve as Principal Investigators (PIs) for FDA-regulated clinical trials.
  • Existing guidelines do not restrict PI roles exclusively to physicians.
  • Clarifying these guidelines empowers PAs to pursue and excel in PI positions.

Conclusions:

  • Physician Associates/Assistants are qualified to be principal investigators in clinical trials.
  • Addressing this misconception will broaden access to clinical research leadership.
  • Implementation of a support plan is recommended for PAs pursuing PI roles.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.5K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
927
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151